Compound information
- Natural Products
- ZC1626017
- Molecular Formula
- C11H11BrO
- Molecular Weight
- 237.999327072 g/mol
- Structure
-
- IUPAC Name
- 2-bromo-1-(4-cyclopropylphenyl)ethanone
- InChI
- InChI=1S/C11H11BrO/c12-7-11(13)10-5-3-9(4-6-10)8-1-2-8/h3-6,8H,1-2,7H2
- InChI Key
- YIPSEYWLPHHHND-UHFFFAOYSA-N
- SMILES
- O=C(CBr)c1ccc(C2CC2)cc1
- Source
- ZINC000306696894
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 13 | Ring Count | 2 |
Heteroatom Count | 2 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 1 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 17.07 Å2 | LogP | 3.346 |
LogS | -3.907 | LogD | 2.653 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.037 | Pgp substrate | 0.013 |
HIA | 0.963 | F20 % | 0.993 |
F30 % | 0.979 | Caco-2 | -4.303 |
MDCK | -4.486 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.99 | PPB | 84.923 |
VD | 1.491 | Fu | 0.936 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.993 | CYP1A2 substrate | 0.412 |
CYP2A6 substrate | 0.794 | CYP2B6 substrate | 0.703 |
CYP2C19 inhibitor | 0.833 | CYP2C19 substrate | 0.675 |
CYP2C8 substrate | 0.635 | CYP2C9 inhibitor | 0.621 |
CYP2C9 substrate | 0.339 | CYP2D6 inhibitor | 0.255 |
CYP2D6 substrate | 0.374 | CYP2E1 substrate | 0.223 |
CYP3A4 inhibitor | 0.023 | CYP3A4 substrate | 0.381 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.362 | CL | 5.94 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.261 | Hepatotoxicity | 0.995 |
Mutagenicity | 0.231 | Rat Oral Acute Toxicity | 0.779 |
FDAMDD | 0.295 | Skin Sensitization | 0.996 |
Carcinogenicity | 0.916 | Eye Corrosion | 1.0 |
Eye Irritation | 0.985 | Respiratory Toxicity | 0.99 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 2.44 | IGC50 | 5.58 |
LC50FM | 5.635 | LC50DM | 5.858 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.302 | NR-AR-LBD | 0.325 |
NR-AhR | 0.267 | NR-Aromatase | 0.035 |
NR-ER | 0.771 | NR-ER-LBD | 0.614 |
NR-PPAR-gamma | 0.649 | SR-ARE | 0.862 |
SR-ATAD5 | 0.792 | SR-HSE | 0.739 |
SR-MMP | 0.062 | SR-p53 | 0.611 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.